Resveratrol Increases Glutamate Uptake, Glutathione Content, and S100B Secretion in Cortical Astrocyte Cultures
- 7 June 2007
- journal article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 27 (5) , 661-668
- https://doi.org/10.1007/s10571-007-9152-2
Abstract
Resveratrol (3,5,4′-trihydroxy-trans-stilbene) is a polyphenol present in grapes and red wine, which has antioxidant properties and a wide range of other biological effects. In this study, we investigated the effect of resveratrol, in a concentration range of 10–250 μM, on primary cortical astrocytes; evaluating cell morphology, parameters of glutamate metabolism such as glutamate uptake, glutamine synthetase activity and glutathione total content, and S100B secretion. Astrocyte cultures were prepared of cerebral cortex from neonate Wistar rats. Morphology was evaluated by phase-contrast microscopy and immunocytochemistry for glial fibrillary acidic protein (GFAP). Glutamate uptake was measured using l-[2,3-3H]glutamate. Glutamine synthetase and content of glutathione were measured by enzymatic colorimetric assays. S100B content was determined by ELISA. Typical polygonal morphology becomes stellated when astrocyte cultures were exposed to 250 μM resveratrol for 24 h. At concentration of 25 μM, resveratrol was able to increase glutamate uptake and glutathione content. Conversely, at 250 μM, resveratrol decreased glutamate uptake. Unexpectedly, resveratrol at this high concentration increased glutamine synthetase activity. Extracellular S100B increased from 50 μM upwards. Our findings reinforce the protective role of this compound in some brain disorders, particularly those involving glutamate toxicity. However, the underlying mechanisms of these changes are not clear at the moment and it is necessary caution with its administration because elevated levels of this compound could contribute to aggravate these conditions.Keywords
This publication has 40 references indexed in Scilit:
- Glutamate, a neurotransmitter—And so much more: A synopsis of Wierzba IIINeurochemistry International, 2006
- The glutamate/GABA‐glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transferJournal of Neurochemistry, 2006
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Resveratrol as an anticancer nutrient: molecular basis, open questions and promisesThe Journal of Nutritional Biochemistry, 2005
- Unique Properties of Polyphenol Stilbenes in the Brain: More than Direct Antioxidant Actions; Gene/Protein Regulatory ActivityNeurosignals, 2005
- Differential regulation by protein kinases of activity and cell surface expression of glutamate transporters in neuron-enriched culturesNeurochemistry International, 2005
- Chemotherapeutic potential of the chemopreventive phytoalexin resveratrolDrug Resistance Updates, 2004
- Neuroprotective effects of resveratrol against β‐amyloid‐induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase CBritish Journal of Pharmacology, 2004
- Excitotoxicity in glial cellsEuropean Journal of Pharmacology, 2002
- Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?Trends in Pharmacological Sciences, 1998